
Atara Biotherapeutics Investor Relations Material
Latest events

AGM 2024
Atara Biotherapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Atara Biotherapeutics Inc
Access all reports
Atara Biotherapeutics Inc. is a biotechnology company focused on developing therapies for cancer, autoimmune, and viral diseases. The company specializes in allogeneic T-cell immunotherapy, using off-the-shelf T-cells to target and treat diseases. Atara's lead programs are centered around developing treatments for conditions such as Epstein-Barr virus-associated cancers and multiple sclerosis. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Atara Biotherapeutics Inc


Q3 2024
Atara Biotherapeutics Inc


Q1 2024
Atara Biotherapeutics Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ATRA
Country
🇺🇸 United States